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Abstract
The high propensity of insulin to fibrillate causes severe biomedical and biotechnological complications. Insulin fibrillation
studies attain significant importance considering the prevalence of diabetes and the requirement of functional insulin in
each dose. Although studied since the early years of the 20
th century, elucidation of the mechanism of insulin fibrillation has
not been understood completely. We have previously, through several studies, shown that insulin hexamer dissociates into
monomer that undergoes partial unfolding before converting into mature fibrils. In this study we have established that NaCl
enhances insulin fibrillation mainly due to subtle structural changes and is not a mere salt effect. We have carried out
studies both in the presence and absence of urea and Gdn.HCl and compared the relationship between conformation of
insulin induced by urea and Gdn.HCl with respect to NaCl at both pH 7.4 (hexamer) and pH 2 (monomer). Fibril formation
was followed with a Thioflavin T assay and structural changes were monitored by circular dichroism and size-exclusion
chromatography. The results show salt-insulin interactions are difficult to classify as commonly accepted Debye-Hu ¨ckel or
Hofmeister series interactions but instead a strong correlation between the association states and conformational states of
insulin and their propensity to fibrillate is evident.
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Introduction
Protein aggregation has serious biochemical, physiological and
clinical implications [1,2]. More than 20 diseases have been found
to owe their etiology to amyloid aggregation of proteins [2].
Amyloid protein deposits consist of linear fibrils ,20 A ˚ wide and
1–6 nm long [3] that possess cross b structure [4,5] and exhibit
birefringence of bound Congo red under polarized light [6]. The
observation that stable globular proteins form fibrils on destabi-
lization [7] and the ability of proteins or polypeptides to form
fibrils independent of their origin, class or function [8,9,10,11]
have led to a common belief that conformational switches from the
native state are responsible for fibrillation [12,13]. This is sup-
ported by reports in which the propensity of a protein to fibrillate
is enhanced under destabilizing conditions owing to buildup of
partially-folded intermediates, such as, by denaturants [14],
mutations [15,16], co-solvents [17], temperature [18], pH [19]
or other [20,21,22].
Insulin is a 51-residue hormone that exists as equilibrium
mixture of hexamer, tetramer, dimer and monomer in solution.
The protein is predominantly hexameric in the presence of zinc at
neutral pH (also the biological storage form), monomeric in 20%
acetic acid (pH 1.8) and dimeric in 20 mM HCl (pH 2.0) [14].
Insulin forms amyloid-like fibrils [23,24] that pose a variety of
problems in its biomedical and biotechnological applications
(especially in insulin pumps). Amyloid deposits of insulin have been
observed both in patients with type II diabetes and in normal
aging, as well as after subcutaneous insulin infusion and after
repeated injection. Recent literature indicates increasing incidence
of insulin amyloid in clinical situations [25,26,27,28,29,30,31].
Injected insulin seems to form fibrils irrespective of the site of
injection. For example, amyloid insulin was observed in thighs
[26,27], shoulders [28], arms [30], and abdominal walls [29,30,31]
of patients at or around the site of repeated injections. Amyloid in
these cases was also observed to be formed irrespective of the type
[25,26] or source [30] of insulin. The studies of insulin aggregation
therefore have immense application in improving insulin therapy
prescribed to diabetic patients. This is important, as the number of
people suffering from this disease is immense. In 2000, 171 million
people were estimated to be suffering from diabetes and the
number is expected to increase to 300 million in 2030 [32]. It is
important to mention here that the clinical cases of insulin amyloid
may seem few as detected in the developed countries with advan-
cement in pumps, pens and insulin preparations but at the same
time it is rational to think how these incidences would translate in
the underdeveloped or developing world, especially countries load-
ed with the population burden.
Studies on insulin aggregation started in the early years of 20
th
century. Soon after pure insulin was purified by Abel [33], insulin
was observed to form precipitates at high temperature and low pH
[34,35]. Waugh showed that the precipitates were fibrilar in
nature with EM and birefringence experiments [36] and that the
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with seeding [23]. A number of investigations have been
undertaken to elucidate the mechanism of insulin fibrillation
[24,37,38,39]. It has been proposed that insulin fibrillation occurs
through dissociation of oligomers into monomers and that the
monomer undergoes a structural change to a conformation having
strong propensity to fibrillate [23,24,26,40,41]. In our previous
studies we have discussed in detail the involvement of conforma-
tional modifications of insulin towards its fibrillation[14,20,42,
43,44]. Insulin fibrillation was accelerated by low to moderate
concentrations of guanidine hydrochloride (Gdn.HCl) at physio-
logical pH due to hexamer dissociation [14]. The predominant
species under these conditions was a partially folded monomer that
was present even at .6 M Gdn.HCl. Similarly for monomeric
insulin (pH 2), Gdn.HCl induced partially folded conformations
enhanced insulin fibrillation [14]. When treated with urea, the rate
of insulin fibrillation increased with increase in the accumulation
of modified monomeric form of protein that sustained even above
8.0 M urea. Surprisingly, addition of low concentrations of urea at
low pH resulted in generation of a compacted conformational state
of insulin that exhibited resistance towards fibrillation [42].
Dissecting further we found that both chain-A and chain-B of
insulin were capable of forming fibrils individually [44]. Thus, a
minimum pathway for insulin fibrillation was postulated i.e., hex-
amerRmonomerRpartially unfolded monomerRfibrils [14,42].
In the present study, we have tried to investigate the effect of
NaCl on the fibrillation of insulin and to propose that structural
changes caused by NaCl are the real contributors to enhanced
fibrillation observed in the presence of NaCl. We carried out studies
with or without urea and Gdn.HCl and have attempted to compare
the relationship between conformation of insulin induced by NaCl
with respect to urea and Gdn.HCl and their propensity to fibrillate,
both at pH 7.4 (hexameric) and pH 2 (monomeric). Fibrillation
kinetics was followed with a Thioflavin T (ThT) binding fluo-
rescence assay [45] and circular dichroism and size-exclusion
chromatography was used to monitor the structural changes taking
place during the course of study. Taken together, the data shows a
strong correlation between the association and conformational
states of insulin and their propensity to fibrillate. The results, in
conjunction with earlier studies on insulin fibrillation [14,23,43,44],
enhance our understanding of insulin fibrillation and will be useful
in formulating insulin therapies.
Materials and Methods
Preparation of samples
Stock solutions of human insulin (2–10 mg/mL) were prepared
fresh before use in 25 mM HCl pH 1.6. For experiments starting
with hexameric insulin, aliquots of 1 M HEPES buffer were added
to obtain a final concentration of 50 mM HEPES and adjusted to
pH 7.4 using NaOH. For studies of monomeric insulin, a stock
solution was freshly prepared by dissolving human insulin in 20%
acetic acid (pH 2.0). The concentration of insulin was determined
by using an extinction coefficient of 1.0 for 1 mg/mL at 276 nm
[46]. The concentration of urea and Gdn.HCl solutions was
obtained by refractive index measurement. Stock (1 mM) solutions
of ThT were prepared by dissolving ThT in doubly distilled water
and the concentration determined using a molar extinction
coefficient of 24,420 M
21 cm
21 at 420 nm. ThT was stored at
4uC, protected from light. Aliquots from the insulin stock solutions
were added to the solutions containing the desired concentrations
of urea, Gdn.HCl and NaCl either individually or in combination
to in a way to reach final concentrations of 2 mg/mL protein,
50 mM HEPES and 20 mM ThT for studying the effect of various
solutions on conformation and fibrillation. In the case of studies at
pH 2, aliquots were added to each sample to reach a final con-
centration of 20% acetic acid, 2 mg/mL human insulin, 20 mM
ThT and varying urea, Gdn.HCl or NaCl concentrations.
Kinetics of fibrillation
ThT fluorescence was monitored for each sample in a 96-well
plate in a Fluoroskan Ascent CF fluorescence plate reader (Lab
Systems) at 37uCo r4 0 uC and shaking at 760 rpm. The plate was
sealed with Mylar plate sealing film (Thermo Labsystems, MA,
USA). The excitation wavelength was 444 nm and the emission
measured at 485 nm. Plates were continuously shaken for the
entire period of study at a rotation diameter of 1 mm and the
integration period was fixed at 20 ms for each well. Five replicates,
corresponding to five wells for each sample, were used to minimize
well-to-well variation. Results from .4 similar profiles were
averaged for the final results at each urea concentration. The
kinetic profiles were analyzed for lag time by curve fitting, using
SigmaPlot software [14,21].
Circular Dichroism (CD)
CD spectra were taken at 25uC on an AVIV 60DS circular
dichroism spectrophotometer (Aviv Associates, Lakewood, NJ).
Varying concentrations of urea, NaCl and Gdn.HCl, individually
or in combination, were prepared in 50 mM HEPES pH 7.4 or
20% acetic acid, respectively. Aliquots from insulin stock solutions
were mixed to obtain a final concentration of 2 mg/mL protein.
To eliminate contributions from buffer, solutions without protein
were prepared in the same manner as above and their spectra
subtracted from the protein spectra. Samples were incubated for
two hours before collecting the spectra. Near-UV spectra were
recorded using a step size of 0.5 nm and a bandwidth of 1.5 nm in
a cell of 0.5 cm path length. Phase diagrams were constructed by
plotting molar ellipticity at 273 nm against 252 nm as reported in
our previous studies [14].
Size exclusion chromatography (SEC)
SEC was performed using a Superose 12 HR 10/30 column
from Pharmacia Biotech. (Exclusion limit 26106 Mr). The column
was run on an FPLC GP 250-P500 (Pharmacia Biotech) in-
strument at a flow rate of 0.5 mL/min with detection at 280 nm.
Human insulin, 2 mg/mL was incubated in 50 mM HEPES
pH 7.4, with and without urea or a combination of urea+NaCl,
urea+Gdn.HCl for 2 hours at 25uC. Aliquots of 200 mL of each
sample were loaded on the column, which was equilibrated with
50 mM HEPES buffer containing the desired concentration of
urea, urea+NaCl or urea+Gdn.HCl prior to the loading of sample.
Aprotonin (6.5 kD) and cytochrome c (12.3 kD), corresponding to
monomeric and dimeric insulin, were run as markers in the
presence of 0.5 M urea, 50 mM HEPES pH 7.4. Since no
significant changes in these proteins have been observed in 0.5 M
urea, these markers were assumed to be globular under these
conditions. The observed elution volume of 15.0 mL and 14.0 mL
(data not shown) for aprotonin and cytochrome c is consistent with
their size.
Results
ThT studies
We monitored fibrillation of insulin with ThT fluorescence as
we have previously used this assay to monitor fibrillation of
different proteins [14,21,22]. Fig. 1A shows the representative
profiles of ThT fluorescence obtained after incubating insulin
(2 mg/mL) in the presence of constant 4 M urea and varying
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‘lag phase’, ‘elongation phase’, and ‘maturation phase’ of
fibrillation kinetics. Changes in the lag phase have been shown
to directly reflect the kinetics of fibrillation [21] compared to
elongation and maturation phase [42]. A decrease in the lag time
indicates faster fibrillation [14,21,42]. Fig. 1B summarizes changes
in the lag phase of insulin (calculated according to [21]) in the
presence of different NaCl concentrations with or without urea at
pH 7.4. In the absence of urea, lag time of hexameric insulin
decreases by more than 50% upon addition of 1 M NaCl and
decreased further with increasing NaCl concentrations. Lag time
reduced to ,25% of the control in the presence of 4 M NaCl. In
the presence of 2 M urea, lag time was observed to decrease by
60% in agreement with the previously published results [42]. Lag
time was observed to further reduce upon addition of increasing
concentrations of NaCl at constant 2 M urea. As expected, a
decrease in the lag time by more than 70% was observed for 4 M
urea treated insulin, which further decreased upon addition of
1 M NaCl at constant 4 M urea. However, the lag time exhibited
a slight increase upon further addition of NaCl (2 or 3 M NaCl)
under these conditions. Taken together these results infer that the
presence of NaCl further accelerates the rapid fibrillation induced
by urea for insulin except for conditions with 4 M urea:2–3 M
NaCl. Studies carried out in 20% acetic acid (pH 2, monomeric
insulin) show a similar accelerated fibrillation taking place in the
presence of NaCl and urea. For monomeric insulin we observed a
20% reduction in the lag time that reduced drastically by 80%
after addition of 1 M NaCl. The limitations in ThT assay (of
monitoring a kinetic association process) under these experimental
conditions obscured exploring the differences in lag time on
further addition of NaCl, however, the rate of fibrillation remained
enhanced in the presence of all NaCl concentrations studied. In
the absence of NaCl, 2 or 4 M urea increased fibrillation of insulin
that increased further upon addition of NaCl. Overall, the
presence of NaCl was observed to induce more intense fibrillation
for monomeric insulin than for hexameric insulin. We also studied
the effect of addition of Gdn.HCl to compare the effect of addition
of NaCl (see also Figure S1). We have previously shown that
addition of Gdn.HCl and urea results in the faster fibrillation for
hexameric insulin [14,42]. 2, 4 or 7 M urea exhibited enhanced
fibrillation by itself. Addition of 0.25–1 M Gdn.HCl in the
presence of 2 M urea induced faster fibrillation in insulin
compared to urea alone. The fibrillating capacity further increased
at higher urea concentrations in combination with 0.25–1 M
Gdn.HCl.
Near UV CD
The representative spectra of insulin in the presence of NaCl
only and in a combination of urea:Gdn.HCl are shown in figure 2A
& 2B, respectively. A characteristic negative peak at 276 nm (due
to aromatic tyrosines) is observed for native insulin in all cases as
reported earlier [14,42]. For monomeric insulin, only the intensity
Figure 1. Kinetics of insulin fibrillation. Panel A shows representative sigmoidal curves of insulin fibrillation obtained at increasing NaCl
concentrations in the presence of 4 M urea pH 7.4. The profiles are a plot of ThT emission max at 482 nm with respect to time. Panel B shows
changes in the lag time of insulin fibrillation obtained from ThT plots at increasing NaCl concentrations in the presence of either 0 M (circles), 2 M
(inverted triangles) or 4 M urea (squares) at pH 7.4. Panel C exhibits changes in the lag time with increasing NaCl concentrations in the presence of
either 0 M (circles), 2 M (inverted triangles) or 4 M urea (squares) at pH 2. Panel D shows changes in the lag time with increasing Gdn.HCl
concentrations in the presence of either 0 M (circles), 2 M (inverted triangles) or 7 M urea (squares) at pH 7.4.
doi:10.1371/journal.pone.0027906.g001
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addition of NaCl subtle changes occurred in the peak at 276 nm,
however, the peak around 252 nm underwent significant changes.
Wavelength 252 nm has been attributed to disulfide bonds in CD
spectra [47,48]. Insulin possesses three disulfides. A plot of changes
in intensity at 253 nm against the concentration of NaCl, pH 7.4,
(Figure 2C) shows that the intensity of this peak decreases upon
addition of increasing NaCl concentrations indicating a structural
rigidity induced around the disulfide bonds. Addition of urea (2 or
4 M) led to loss of structure around tyrosines (276 nm) in insulin
but the disulfide environments were found to be more ordered
matching our previous studies [42]. Presence of NaCl in addition
to urea led to further orientation of the disulfides towards rigidity
with the effect being more pronounced at 2 M urea than 4 M urea
in combination with NaCl. The disulfide region of monomeric
insulin (Figure 2E) exhibited the reverse trends. The intensity of
peak at 253 nm exhibited an increase on addition of NaCl
showing that the structure was getting more flexible up on addition
of NaCl. Addition of urea (2 or 4 M) by itself led to ordering in the
disulfide environments but in the presence of NaCl the significant
dis-organization of structure around disulfides was observed. We
thus can conclude while at pH 7.4 disulfide environments get
rigid, at pH 2 a considerable flexibility in structure was attained
upon addition of NaCl. We wanted to compare the effect of the
urea:NaCl pair to the effects caused by Gdn.HCl or ur-
ea:Gdn.HCl. Since Gdn.HCl is a strong reagent we used only
Figure 2. Structural changes of insulin. Panel A exhibits representative near-UV CD spectra of insulin at different NaCl concentrations at pH 2
and Panel B shows spectra at different Gdn.HCl concentrations at pH 7.4. Panel C shows changes in molar ellipticity at 252 nm with increasing NaCl
concentration in the presence of either 0 M (filled circles), 2 M (open circles) or 4 M urea (inverted triangles) at pH 7.4. Panel D shows % changes in
molar ellipticity at 273 nm with increasing Gdn.HCl concentration in the presence of either 2 M (filled circles), 4 M (open circles) or 7 M urea (inverted
triangles) at pH 7.4 (For raw data of Panel D please refer to Figure S3). Panel E shows changes in molar ellipticity at 252 nm with increasing NaCl
concentration in the presence of either 0 M (filled circles), 2 M (open circles) or 4 M urea (inverted triangles) at pH 2. Panel F shows changes in molar
ellipticity at 252 nm with increasing Gdn.HCl concentration in the presence of either 2 M (filled circles), 4 M (open circles) or 7 M urea (inverted
triangles) at pH 7.4.
doi:10.1371/journal.pone.0027906.g002
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solubility problems and carry out studies in combination with 7 M
urea. The sequence of addition of chaotropes did not seem to
influence the end result (Figure S2). Figure 2B shows considerable
changes in the shape and intensity of insulin spectra both around
252 and 276 nm at pH 7.4 with addition of Gdn.HCl (0.5 or
1 M). This indicates that unlike the localized effect by NaCl,
Gdn.HCl induces global structural changes in insulin. To get a
better insight we plotted the changes in the intensity at 273 nm as
% changes against Gdn.HCl (for raw data please refer to Figure
S3). The combination of denaturants resulted in 10% loss of
structure compared to control insulin at 2 M urea:1 M Gdn.HCl.
A 30% disruption was observed at 4 or 7 M urea:1 M Gdn.HCl.
Interestingly, the changes in disulfide environment were not
monotonous. In the presence of 2 or 4 M urea:0.5 M Gdn.HCl
the loosening of structure around disulfide group was observed
while addition of 1 M Gdn.HCl seemed to re-orient the disulfide
towards the environment in control insulin. Contrary to this, in
7 M urea, addition of Gdn.HCl lead to increasing organization of
structure around disulfides with the increase in Gdn.HCl con-
centration. In conclusion, all these experiments show subtle and
gross structural changes taking place in insulin. At this stage, it can
be arbitrarily assumed that insulin is in different conformational
states depending on the concentration of each added chemical.
To represent the structural perturbations observed in full near
UV CD spectrum better, we plotted the phase diagrams for CD
data. Phase diagrams have been used to simplify complex data
obtained in fluorescence and CD experiments [14,42,49,50]. Each
linear segment represents all-or-none transition between two con-
formations. Phase diagrams with present data were obtained by
plotting molar ellipticity at 273 nm vs 253 nm. These were
chosen, as these are the wavelengths were the changes occur or are
supposed to occur. In each graph of Figure 3 the concentration of
urea:NaCl or urea;Gdn.HCl is shown next to the data point. The
concentration of urea has been shown in bold and that of NaCl or
Gdn.HCl has been shown underlined in the figure. Figure 3A
shows a single transition taking place in all the three sets of studies
indicating the existence of at least two structurally different states
in each set (6 states in all). Monomeric insulin (Figure 3B) shows
structural transformation between two states in the presence of
NaCl only but in combination with urea NaCl results in formation
of an additional conformation at 1.25 M (8 states in this set).
Gdn.HCl and urea by itself have been shown to induce multiple
conformational states in insulin [14,42]. In Figure 3C presence
of Gdn.HCl in combination with 2 or 4 M urea results in the
formation of three structurally different states in each set. In-
terestingly, in the mostly unfolded insulin at 7 M urea, addition of
Gdn.HCl is able to unfold it into another distinct conformation.
Taken together the CD data analysis emphasizes that NaCl by
itself is able to induce structural changes in insulin, especially
around the disulfide region and in combination with urea is able to
further modify its structure.
SEC studies
Another way to compare the structural changes induced by
NaCl, NaCl:urea or urea:Gdn.HCl is by SEC. Figure 4A shows
Figure 3. Phase diagram indicating the transitions taking place in the insulin. Diagrams have been obtained by plotting molar ellipticity at
252 and 273 nm from the near-UV CD. Numbers in panel A and B indicate molar concentration as urea (bold):NaCl (underlined) of the nearest point
and in panel C that as urea(bold):Gdn.HCl (underlined) of the nearest point, respectively. Panel A exhibits a phase diagram for data obtained at pH 7.4
at different concentrations of urea and NaCl. Panel B exhibits a phase diagram obtained at pH 2 in the presence of different concentrations of urea
and NaCl. Panel C exhibits a phase diagram for data obtained at pH 7.4 at different concentrations of urea and Gdn.HCl.
doi:10.1371/journal.pone.0027906.g003
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concentrations of NaCl and urea at pH 7.4, (solid line) 2 M urea:1 M NaCl, (dotted line) 2 M urea:2 M NaCl, (dashed line) 2 M urea:3 M NaCl. Panel B
shows representative SEC profiles obtained in the presence of varying concentrations of Gdn.HCl and Urea at pH 7.4, (solid line) 2 M urea:0 M
Gdn.HCl, (dotted line) 2 M urea:0.5 M Gdn.HCl, (dashed line) 2 M urea:1 M Gdn.HCl. Vertical dotted lines on Panel A and B corresponding to elution
volumes at max peak heights. Panel C provides overall SEC analysis. The three solid lines act as markers for the monomeric, dimeric and hexameric
insulin based on SEC elution volumes (mL). Symbols show the elution volume of the associated species of insulin (mono- or multi-meric state) and the
arrows on the symbols show the intensity (scaled down in millimeters) of the corresponding peaks in the range of this study. Filled circles represent
elution volumes (mL) at different urea and NaCl concentrations as shown along the ordinate axis corresponding to each data point. Filled squares and
inverted triangles represent the elution volumes (mL) of insulin treated with different concentrations of urea and Gdn.HCl shown accordingly on the
ordinate axis.
doi:10.1371/journal.pone.0027906.g004
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at 12 mL and 14 mL correspond to the elution volumes of cy-
tochrome c (12.3 kD, ,insulin dimer) and aprotonin (6 kD,
,insulin monomer), respectively. We have extensively analyzed
and characterized similar SEC studies for insulin previously
[14,42]. The elution volume of insulin at pH 7.4 (hexamer) was
6.4 mL (not shown). In the presence of 2 M urea insulin eluted
with maximum peak intensity at 11.5 mL indicating a form larger
than dimer. Addition of 0.5 M Gdn.HCl led to the dissociation of
this structure to a dimeric and monomeric form as evidenced by
the change in their elution volumes corresponding to standards for
dimeric and monomeric insulin. Increasing Gdn.HCl concentra-
tion to 1 M led to shift in the dissociation equilibrium towards the
monomeric form of insulin. Figure 4C summarizes the SEC results
obtained at other combinations of Gdn.HCl and urea. The sym-
bols in the figure indicate elution volumes and the arrows on top
of symbols indicate the intensity of the peak corresponding to that
elution volume. The length of each arrow (scaled down in
millimeters) corresponds to the max height of the particularly peak
at that elution volume (does not imply quantitative analysis). For
example, for 2 M urea:0 M Gdn.HCl a peak corresponding
to species larger than dimer form was observed. Addition of
Gdn.HCl (0.5 or 1 M) dissociated insulin into a dimer and
monomer with slight changes in intensities. Compared to this at
4 M urea the presence of 1 M Gdn.HCl caused pronounced
changes in the intensity of monomer compared to another point in
this set. Addition of 1 M Gdn.HCl with 7 M urea shifted the
equilibrium absolutely to monomeric insulin. However, the studies
carried out in the presence of NaCl were not so clear. Addition of
1 M NaCl in combination of 2 M urea (Figure 4A) increased the
elution volume slightly but the size of the peak increased indicating
either a loosening of a structure or dissociation into rapidly
exchanging states. Increasing NaCl concentration to even 3 M did
not yield a clear dissociation of insulin but instead broad peaks
eluting between the standard proteins were observed. Based on
our earlier studies [14,42] we assume a scenario where a fast
equilibrium between tetramer and dimer is taking place in the
former case and between a monomer and dimer in the latter two
cases, respectively. The same effect was observed at other
combinations of urea and NaCl (Figure 4C). Even at 4 M urea
and 4 M NaCl or 6 M urea and 1 M NaCl no distinct dissociation
into monomer or dimer was observed.
Discussion
The concept of ‘conformational disease’ holds its etiology to the
existence of the processes of misfolding or toxic folding. In vitro
studies on suspect proteins have mostly shown faster propensities
to fibrillate in altered conformations with respect to their native
state including the class of natively unfolded proteins [51]. In the
case of unfolded proteins it seems straight forward that addition of
compounds that interact (directly or indirectly) with the backbone
or shield (repulsive/attractive) moieties result in significant effect
on the association of the molecule concerned. But with globular
proteins unless the added compound/condition possesses strong
disruptive properties a significant change in its association pro-
bability are hard to fathom.
The studies become more interesting as the dichotomy of
solvents get increasingly blurred. For example, Gdn.HCl and urea,
known chaotropes, modify the structure of insulin. These modified
forms have been found to be aggregation-prone intermediate
species that stimulate the fibrillation kinetics of insulin [14,42].
However, the effect of addition of NaCl or other salts on insulin
cannot be explained as clearly. Salts in general have been observed
to mediate through ion interactions - Debye-Hu ¨ckel screening [52]
or electroselectivity series [53,54], or by influencing water-solute
interactions - Hofmeister series [55,56,57]. Different proteins have
been shown to interact with salts in their own unique way during
fibrillation process. b-microglobulin [58] and glucagon [59] have
been observed to follow electroselectivity series of interactions
while a-Synuclein has been observed to follow Hofmeister series of
interactions [60] with salts. The identification of real interactions
becomes more complex as Ab has been reported to follow both
Hofmeister and anion binding series [61]. In addition, yeast PrP
Sup35 followed Hofmeister series [62] while the mouse PrP has
been observed to follow the electroselectivity series [63]. Further, it
has been reported that same salt shows a biphasic effect, that is, at
low concentrations it induce opposite effect of that induced at
higher concentrations under similar conditions [58,64]. Thus, as
acknowledged by Munishkina et al., [60], the salt effects are a
combination of the electrostatic and solvent interactions besides
other exogenous and endogenous factors. We believe the one
additional effect of salts that has been overlooked so far is their
contribution to the structural modification of the protein and this
may be a bigger player in rendering the susceptibility of protein
towards fibrillation. This statement is supported by finding where
glucose oxidase has been found to undergo structural changes
upon addition of monovalent salts leading to the stability of this
enzyme [65]. We will try to explain our results in light of these
arguments as below. We have used high amounts of salt mainly to
get an overall picture for our studies. Although not insulin specific,
the high concentration salt studies should not be considered
physiologically irrelevant as during anti-diuresis the medullar fluid
similarities can increase up to ,2.0 M NaCl (equivalent of
3800 mOsmol l
21) in mammalian kidneys (reviewed in [66]).
It has been proposed that the Debye-Hu ¨ckel screening effect
should be influenced by the ionic strength whereas the Hofmeister
series undergoes an inversion as a function of pH [60]. Also, NaCl
has been shown to induce maximum fibrillating effect at a con-
centration of 200 mM whereas other sodium salts are able to
reach similar changes at 4–60 times less concentration [58,64].
Our ThT data at pH 2.0 with NaCl shows an enhancement in the
fibrillation with the increase in the concentration of NaCl from
lower concentrations (0.5 M) to higher (3 M). The trend continued
to follow even in the presence of urea. On the other hand,
Gdn.HCl at pH 7.4 exhibits a relatively gradual increase in ThT
kinetics upon addition of Gdn.HCl both in the presence and
absence of urea probably due to the narrow range of concentra-
tion included in this study (0–1 M). Taken alone this behavior then
follows the Debye-Hu ¨ckel rules of more screening with more ionic
strength. However, at pH 7.4 insulin without urea compares well
with the monotonous trend observed in the above-mentioned cases
but in the presence of urea there are subtle deviations in that the
effects on ThT kinetic seem to reverse above 2 M NaCl con-
centrations. This could be explained in terms of the structural
changes induced by the salt much like the A states reported by
Goto et al., [67]. Conversely, the ion reverses its effect upon
change in the global structure of protein.
The changes observed in CD spectra are reproducible in NaCl,
urea or Gdn.HCl thereby making the data robust. Also, if we
compare it with our previously published CD profiles for insulin
[14,42] the changes in the data around 253 nm are significantly
reproducable and exhibit a definite trend. The attempts to obtain
far-UV CD profiles were coumpounded by the presence of high
salt concentrations especailly below 210 nm. However, the signal
at 222 nm appeared to be similar at different salt concentrations
leading us to conclude that no significant change in secondary
structure take place upon addition of NaCl.
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concentrations in CD studies however show two different effects.
At pH 7.4 the increasing salt concentration seems to induce
structural rigidity around the disulfide bonds whereas at pH 2 the
structure seems to get loosened around the disulfides with an
increase in the salt concentration. This is typical of the Hofmeister
effect where ions reverse the effect as a function of pH. In the case
of Gdn.HCl studies and in the presence of low urea concentrations
we observed a structure inducing effect as a function of NaCl
concentration but at 7 M urea a linear loss in the structure around
disulfides was observed with the addition of NaCl. Thus, we see
a role reversal from pH 7.4 to 2, from hexameric form to mono-
meric form, or from folded form to largely unfolded form. The
latter effect could also be compared to Goto et al., [67] as above.
Thus, from these comparisons it is not easy to discern the real
effects taking place (neither Debye-Hu ¨ckel nor Hofmeister series
could be generalized) but what stands out is the relation with the
structural changes and propensity to aggregate. This is further
supported by the SEC and CD data. NaCl increases the dis-
sociation of urea treated or urea untreated insulin and induces
similar changes at pH 7.4 in the CD spectra. In addition, insulin
populated distinct conformational states as evident in phase
diagrams comparable to Gdn.HCl at lower pH. Also the observed
dissociation of insulin induced with NaCl in this study is similar to
dissociation induces by urea alone in our previous SEC studies
[42]. From this discussion it follows that whether the effect is due
to screening, specific ion-pair interaction or solvent-protein in-
teractions, it is finally the structural change induced in the mole-
cule that determines its propensity to fibrillate.
From above discussion it seems plausible that the model that fits
these observations could be explained by the help of insulin
structure (PDB ID: 9INS) [68] shown in Figure 5. Chain-A and
chain-B of insulin have been shown in dark and light color,
respectively, in the center of the figure. Three disulfides of insulin
shown by solid arrows lie on the surface of the molecule. On the
right side are the structures exhibiting the surface potential on the
insulin molecule (blue - positive; red – negative, these structures
were obtained by running PDB2PQR version 1.7 [69] on 9INS
followed by processing with APBS software [70]). The pictures
show considerable distribution of both negative and positive
charges on the surface available for interaction with counter ions.
It is most eminent that these ionic interactions lead to the subtle
changes in structure around the surface exposed disulfides. The
induced changes can be enough to drift away the flexible elements
(N- and C- terminal fragments) of insulin generating an
aggregation prone state of the molecule and can further be
Figure 5. Crystal structure of insulin (PDB ID: 9INS) [68] with 906 rotation. Dark colored (blue) element corresponds to chain-A and light
colored (green) to chain-B of insulin in the central structures. The three disulfide bond of insulin have been shown by solid arrows. The dotted arrows
indicate the N- and C-terminal segments of chain-B. The dotted spheres on the left hand side of the figure show the central hydrophobic core of
insulin. The surface potential of insulin molecule (blue - positive; red – negative) obtained after processing by PDB2PQR [69] and APBS [70] has been
shown on the right hand side of the figure. The proposed model of insulin fibrillation is depicted at the bottom of the figure (see text for details).
doi:10.1371/journal.pone.0027906.g005
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(shown with dotted arrow) of chain-B together with the charged
residues in the helices enclose a highly hydrophobic core of the
molecule (shown as the dotted spheres on the left side of Figure 5).
It has been reported by H/D exchange studies that insulin
possesses 10 buried protons belonging to this inner core [71] and
when the core is exposed by subtle changes in the C-terminal
segment of chain-B, it leads to immediate aggregation of insulin
into fibrils [43]. This claim is supported by studies on truncated
despentapeptide insulin (removed B26–B30 residues correspond-
ing to C-terminal segment of Figure 5) that undergoes faster
fibrillation than the full length insulin [72]. In addition, when the
mobility of B-chain C-terminal is restricted by tethering it to N-
terminal of chain-A, a slow transformation of insulin into amorp-
hous aggregates instead of amyloid fibrils is observed [73].
N-terminal of B-Chain is unstructured and in similar spatial
arrangement as C-terminal and thus may behave in a similar
manner (in tandem or in a co-operative manner) as C-terminal.
Studies from Prof. Weiss’s group [74] have extensively detailed the
detachment of N-terminal of both A- and B-chains of insulin in
inducing insulin aggregation. Based on these facts and our data we
suggest a model of insulin amyloid formation under these con-
ditions as shown in Figure 5. Insulin has been shown as a three-
dimensional polar cubic layer covering a hydrophobic core with
the help of N- and C-terminals of B-chain in this model. Due to
slight disturbances in mobile termini a modified form of insulin as
a partially folded intermediate is generated. The modified struc-
ture contains most of the folded contacts but with the inner
hydrophobic core exposed. Thus, the structural change triggers
instantaneous hydrophobic inter-molecular association of more
than one insulin molecule. The association proceeds through as-
sembly into oligomers and protofibrils (containing unknown num-
ber of monomeric insulin units) before transforming into mature
amyloid fibrils. The model compares well with the earlier studies
indicating the involvement of aggregation prone hydrophobic core
in insulin amyloid formation [72,75,76]. This model also compares
well with the proposed model of insulin assembly obtained from
studying insulin fibrils by cryo EM (Fig. 5 in ref [77]).
A review of published data indicates abundant instances depicting
structural transformations in proteins induced by salts. Addition of
monovalent salts has been shown to lead to global compaction of
glucose oxidase rendering it resistant to proteolysis and denaturation
[65]. In the case of dialkylglycine decarboxylase, simple exchange of
monovalent salt anions actuated a structural switch involving just
two surface residues that changed the enzyme activity and induced
changes in the quaternary structure [78]. Alcohol dehydrogenase I
has been reported to be stabilized by NaCl, CaCl2 and MgCl2
through inter-domain electrostatic interactions of the protein [79].
In another study, similar salts have been observed to increase the
conformational stability of RNase T1 through interaction with
surface exposed charged residues [80]. Besides direct interaction
with surface exposed charges, salts can also induce structural
changes through allosteric mechanism. Hexameric insulin (insulin at
pH 7.4 in our studies) in itself has been found to undergo allosteric
transition between three conformational states (T6,T 3R3,a n dR 6)
by ligands and by the coordination of anions to the surface exposed
His-10 in the B-chain [81]. Interestingly, this study also reports
structural changes in N-terminal of B-chain (residues 1–8 that
undergo coil-to-helix transformation) up on changes in the
coordination of metal attached to surface exposed residue His-10.
This finding becomes more relevant since one of the disulfides in
insulin involves residue Cys-7 of N-terminal in B-chain (Figure 5).
These observations greatly favor our proposed model.
Thus, in conclusion, we propose that fibrillation induced by salts
like NaCl is better explained by the property of NaCl to induce subtle
structural changes in the molecule that push aside the N- and C-
terminalsegmentleadingtotheexposureofhighlyhydrophobicinner
core of insulin. This small structural tweaking of insulin by NaCl,
thus, recruits monomeric units of insulin for initial inter-molecular
hydrophobic clumping that in turn leads to rapid and more complex
association of insulin into amyloid fibrils. Keeping in mind that
interaction of salts with proteins are diverse [58,59,60,61,62,63,64]
this effect may only be applicable to proteins like insulin, a-synuclein
[60] and other not yet studied proteins. The phenomenon may also
be clear by revisiting other studied proteins in light of this article.
Supporting Information
Figure S1 Changes in lag time of ThT kinetics with
increasing NaCl at pH 2 in the presence of 0.5 M urea.
Conditions were similar as reported in Figure 1.
(TIFF)
Figure S2 Changes in molar ellipticity at 273 nm with
increasing Gdn.HCl concentration in the presence of
2 M urea. Filled circles show the data obtained after adding
Gdn.HCl to urea treated samples, incubated for 30 minutes and
open circles show the data obtained after adding urea to Gdn.HCl
treated samples and incubated for 30 minutes both at pH 7.4.
(TIFF)
Figure S3 Changes in molar ellipticity at 273 nm with
increasing Gdn.HCl concentration in the presence of
2 M (filled circles), 4 M (open circles) or 7 M urea
(inverted triangles) all at pH 7.4.
(TIFF)
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